Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Spiegelman Daniel K
Relationship:   Director
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   148,092    

Indirect Shares

   6,673      
Direct Value   $4,990,085    

Indirect Value

   $0      
Total Shares   154,765      
Total Value   $4,990,085      


CV Therapeutics Inc $0 Biomarin Pharmaceutical Inc $4,226,410 Myriad Genetics Inc $763,674 CV Therapeutics Inc $0 Biomarin Pharmaceutical Inc $4,226,410 Myriad Genetics Inc $763,674
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            CV Therapeutics Inc CVTX SVP, CFO 2009-04-09 67,489 2009-04-09 6,673    Premium*  
            Cascadian Therapeutics, Inc CASC Director 2018-03-09 0 2009-12-04 0    Premium*  
            Biomarin Pharmaceutical Inc BMRN EVP, Chief Financial O... 2019-04-30 47,686 2012-05-29 0    Premium*  
            Relypsa Inc RLYP Director 2016-09-01 0 2015-06-04 0    Premium*  
            Myriad Genetics Inc MYGN Director 2024-06-04 32,917 2020-05-27 0    Premium*  
* Premium Members only  

Records found :    182         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 7 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
MYGN Myriad Genetics Inc Director   –       •      –    2023-06-01 4 A $0.00 $0 D/D 15,151 49,131 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2015-03-02 4 S $107.00 $1,658,500 D/D (15,500) 68,676 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2015-03-02 4 OE $39.06 $605,430 D/D 15,500 84,176 0 -
MYGN Myriad Genetics Inc Director   –       •      –    2020-12-04 4 A $0.00 $0 D/D 15,889 36,451 0 -
MYGN Myriad Genetics Inc Director   –       •      –    2021-05-27 4 D $0.00 $0 D/D (15,889) 20,562 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2014-09-02 4 OE $39.06 $624,960 D/D 16,000 84,676 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2014-09-02 4 S $69.83 $1,117,314 D/D (16,000) 68,676 0 -
CASC Cascadian Therapeutics, I... Director   –       •      –    2015-06-13 4 OE $0.00 $0 D/D 16,042 56,686 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-03-15 4 A $0.00 $0 D/D 16,640 63,933 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-05-31 4 OE $39.06 $659,958 D/D 16,896 71,235 0 -
MYGN Myriad Genetics Inc Director   –       •      –    2022-06-02 4 A $0.00 $0 D/D 17,275 40,404 0 -
CASC Cascadian Therapeutics, I... Director   –       •      –    2014-03-11 4 OE $0.00 $0 D/D 19,352 43,709 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2015-11-16 4 OE $39.06 $781,200 D/D 20,000 48,229 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2015-11-16 4 AS $104.30 $2,085,918 D/D (20,000) 28,229 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-11-09 4 S $90.61 $1,812,206 D/D (20,000) 23,100 0 -
MYGN Myriad Genetics Inc Director   –       •      –    2020-05-27 4 A $0.00 $0 D/D 20,562 20,562 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-05-31 4 AS $89.35 $1,873,126 D/D (20,841) 50,394 0 -
CASC Cascadian Therapeutics, I... Director   –       •      –    2018-03-09 4 D $0.00 $0 D/D (21,006) 0 0 -
CVTX CV Therapeutics Inc SVP, CFO   •       –      –    2005-08-26 4 S $26.24 $564,317 D/D (21,506) 0 -
CVTX CV Therapeutics Inc SVP, CFO   •       –      –    2005-11-03 4 OE $9.25 $231,250 D/D 25,000 25,000 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2014-02-14 4 A $0.00 $0 D/D 26,250 64,273 0 -
CVTX CV Therapeutics Inc SVP, CFO   •       –      –    2005-11-03 4 S $25.21 $668,065 D/D (26,500) 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2013-05-01 4 S $64.42 $1,803,897 D/D (28,000) 33,000 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2013-05-01 4 OE $39.06 $1,093,680 D/D 28,000 61,000 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2017-02-28 4 OE $63.10 $1,893,000 D/D 30,000 60,347 0 -
  182  Records found
  1   2   3   4   5   6   7  8      
  Page 7 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us